|
Volumn 82, Issue 2-3, 2006, Pages 277-278
|
Screening for Neuroligin 4 (NLGN4) truncating and transmembrane domain mutations in schizophrenia [5]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MEMBRANE PROTEIN;
NEUROLIGIN 4;
UNCLASSIFIED DRUG;
CHROMOSOME MAP;
CHROMOSOME XP;
CONTROLLED STUDY;
FEMALE;
GENE MUTATION;
GENE SEQUENCE;
GENETIC ASSOCIATION;
GENETIC CODE;
GENETIC SCREENING;
GENOTYPE PHENOTYPE CORRELATION;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MUTAGENESIS;
MUTATIONAL ANALYSIS;
NERVE CELL PLASTICITY;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
PROTEIN DETERMINATION;
PROTEIN DOMAIN;
PROTEIN FUNCTION;
SCHIZOPHRENIA;
SEQUENCE ANALYSIS;
SINGLE NUCLEOTIDE POLYMORPHISM;
Y CHROMOSOME;
ADULT;
ALLELES;
CARRIER PROTEINS;
CHROMOSOME MAPPING;
CHROMOSOMES, HUMAN, X;
CHROMOSOMES, HUMAN, Y;
DNA MUTATIONAL ANALYSIS;
EXONS;
FEMALE;
GENETIC SCREENING;
HUMANS;
MALE;
MEMBRANE PROTEINS;
PHENOTYPE;
PILOT PROJECTS;
POLYMERASE CHAIN REACTION;
POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;
REPRODUCIBILITY OF RESULTS;
SCHIZOPHRENIA;
STATISTICS;
|
EID: 33344470000
PISSN: 09209964
EISSN: None
Source Type: Journal
DOI: 10.1016/j.schres.2005.11.003 Document Type: Letter |
Times cited : (12)
|
References (8)
|